-
Glenmark Pharma Share Price in Focus as Goa Facility Gets EIR From USFDA
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
No Comments
Glenmark Pharma share price is in focus after its Goa formulations facility received an Establishment Inspection Report from the USFDA with VAI status.